Press Releases: Drug Discovery/Combinatorial Biology

Press releases
Browse

Press releases

Displaying 1..10 of 15 - per page Next page
Order by

Pharmalicensing highlights top 50 biotech and pharma dealmakers

New summary from Partneringdesk highlights trends in dealmaking from the top pharma and biotech companies More

Aventis Pharmaceuticals makes milestone payment to Astex

Astex Technology today announced the receipt of a milestone payment from Aventis Pharmaceuticals, as part of a structural biology research agreement focused on solving novel human cytochrome P450 Crystal Structures More

Astex announces Alzheimer's drug discovery collaboration with AstraZeneca

Agreement relates to the discovery of novel drugs against a key protein target implicated in Alzheimer's disease More

ML Signs Multi-Million Pound License Agreement With A Major Global Pharmaceutical Group To Develop A Respiratory Treatment In ML's New C200 Inhaler

First commercialisation of C200 inhaler could generate up to £16.5M in development fees and milestone payments plus royalties on sales More

MORPHOCHEM AND GBF SET UP CO-OPERATION AGREEMENT - Tubulysin: new compounds against cancer

Morphochem and GBF have entered into a research collaboration in the area of cancer research, the objective of which is to develop new therapeutics using tubulysins. More

Microarray Analysis

Microarray Analysis Conference: Integrating microarray data analysis approaches into research applications will ensure more efficient drug discovery. More

Isogenica signs collaborative deal with Smiths Industries/Graseby

Strategic Collaboration with Graseby Dynamics to Assess Potential of Isogenica's Covalent Display Technology In Biological Detection Applications More

Isogenica licences CDT to Invitrogen Corp.

Invitrogen to use CDT for discovery of new research reagents More

ASINEX Announces Lead Optimization Deal with Avalon Pharmaceuticals

Asinex will perform chemical lead optimization of compounds discovered through the use of diverse, small molecule collections from both companies. More

Isogenica Launched

Isogenica established after raising $3M More

Displaying 1..10 of 15 - per page Next page
Order by

Your selection

Industry sector: Drug discovery del; Combinatorial biology del

Browse By

Therapeutic target: Accident and Trauma; Allergy; Blood and forming organs; Cardiovascular; Central Nervous System; Dermatological; Endocrinology; Gastrointestinal; Genetic disorders; Genito-urinary; Hospital and Surgery; Immune related disorders; Infectious diseases; Metabolism; Musculoskeletal; Oncology; Oral Health; Other therapeutic; Respiratory; Sensory organ
Year: 2010; 2009; 2008; 2007; 2006; 2005; 2004; 2003; 2002; 2001; 2000; 1999

Products:	Partnering Search	Pay-per-Click	Company Profiling	PL Intelligence	Reports	Comparision
In-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Out-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Companies:	Profiled companies	Industry Sector	Therapeutic Target	Geographic Location	Search	Add your company
Reports:	Biotechnology	Business Development	Management	Market & Sales	Medical Devices	Pharmaceuticals
Jobs:	Pharmaceutical jobs	Browse jobs	Search for jobs	Create your CV	Employer profiles	Post your jobs
Forums:	Talk to an expert	Industry Gossip	Business Development	What's new	Reports	Services
News:	Deals & Alliances	Development	Financial Results	Financings	Intellectual Property	Regulatory
Events:	Pharma events	Calendar	Organizers	Featured events	Search
Articles:	Business Development	Technologies	Events	Legal and regulatory	Therapeutic
Deals:	Industry Sector	Therapeutic Target	Deals Date	Search	Reports	Press releases
About us:	Our Audience	Case Studies	Newsletter	Careers	FAQ	Contact us